November 22, 2024
GHATI: Improving STEMI Management Internationally - ACC 2022

GHATI: Improving STEMI Management Internationally – ACC 2022

Video by PCR via YouTube
Go to Source
GHATI: Improving STEMI Management Internationally - ACC 2022

Mirvat Alasnag interviews Cesar Herrera, Hadley Wilson & Benny Levenson, principal investigators of the GHATI trial: A two-year report of 4,015 patients enrolled in the American College of Cardiology – Global Heart Attack Treatment Initiative.
Two-year outcomes from GHATI showed significant improvements in key clinical endpoints, including cardiogenic shock upon arrival at the hospital, cardiac arrest, LVEF below 40% and survival at discharge, as a result of the program.

View our full #ACC22 coverage here: https://www.pcronline.com/News/Whats-new-on-PCRonline/2022/ACC-2022/PCR-ACC.22-Scientific-Sessions
#STEMI

Go to Source